ImmunityBio (IBRX) Change in Account Payables (2014 - 2026)
ImmunityBio's (IBRX) quarterly Change in Account Payables came in at $3.9 million in Q1 2026, down 39.42% year-on-year from $6.4 million in Q1 2025, and up 298.47% on a QoQ basis from $979000.0 in Q4 2025.
ImmunityBio (IBRX) Change in Account Payables (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Change in Account Payables data on file, last reported at $3.9 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 39.42% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was -$2.7 million, a 161.8% decrease from a year earlier, with the FY2025 full-year figure at -$190000.0, up 94.0% from the prior year.
- Change in Account Payables for Q1 2026 stood at $3.9 million, up from $979000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for IBRX reached as high as $6.4 million in Q1 2025 and fell as low as -$8.9 million in Q3 2024.
- Historically, Change in Account Payables has averaged $121647.1 across 5 years, with a median of $668000.0 in 2023.
- Across the five-year window, Change in Account Payables tumbled 758.35% in 2023 and surged 545.81% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $437000.0 in 2022, then tumbled by 758.35% to -$2.9 million in 2023, then slipped by 11.71% to -$3.2 million in 2024, then soared by 130.46% to $979000.0 in 2025, then soared by 298.47% to $3.9 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $3.9 million in Q1 2026, $979000.0 in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | 3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.90 Mn |
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | 979,000.00 |
| Dec 31, 2025 | 979,000.00 |
| Sep 30, 2025 | -1.39 Mn |
| Sep 30, 2025 | -1.39 Mn |
| Jun 30, 2025 | -6.22 Mn |
| Jun 30, 2025 | -6.22 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | -3.21 Mn |
| Dec 31, 2024 | -3.21 Mn |
| Sep 30, 2024 | -8.92 Mn |
| Sep 30, 2024 | -8.92 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | -2.88 Mn |
| Dec 31, 2023 | -2.88 Mn |